This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

How Cuomo's Pot Law Peer Pressures Corporate America Into the Weed Business

TheStreet reached out to the U.S. Attorney's Office for the Northern District of New York and the U.S. Attorney's Office for the Southern District of New York to ask if the Cuomo administration had preemptively discussed the prospects of an executive action that would permit hospitals in the state to distribute medical marijuana for strict cases. Both offices declined to comment for this story.

TheStreet contacted Gov. Cuomo's office, which did not respond to repeated requests for comment as to whether the governor or members of his administration approached the U.S. Attorney's offices throughout New York about the executive action.

But the U.S. Attorney's office may have no incentive to weigh in publicly on this issue.

"If the office says that they wont pursue prosecutions, then they look soft on crime. If they say they will pursue prosecutions, then they're starting a fight with the governor," Greg Magarian, a Constitutional law professor at Washington University in St. Louis, wrote in an email. "Either way, what they end up doing will probably depend on policy determinations higher up in the Justice Department."

This could dissuade the government from intervening with hospitals that act as dispensaries. But heavily regulated hospitals could be the most trustworthy medical marijuana dispensaries.

Cuomo said in his State of the States speech on Jan. 9 that the program would help to manage pain and treatment of cancer and other serious illnesses. This suggests that the executive action explicitly outline the cases in which the hospitals could prescribe medicinal use. Hospitals are familiar with tight oversight to prescribing prescription drugs.

Who would supply the hospitals and how the suppliers would acquire cannabis remains unknown.

This leaves the state and Cuomo to question what are the economic and political benefits.

The reality is that the progress made on pot legalization is only a recent phenomenon, and it has left researchers with little empirical research to publish definitive conclusions.

"When we started researching this stuff a couple years ago, we were pretty surprised that next to nothing had been done on economic outcomes, or socio-economic outcomes," Mark Anderson, a health economist at Montana State University, said in a phone interview from Bozeman, Montana.

Anderson pointed to the fact that state legislatures didn't begin to pass these laws until the late 1990s as reason for why there is little research.

Cuomo, who many political analysts believe will run for the Democratic nomination in 2016, may have announced this executive action to gain some points as a progressive, but the entrance of hospitals as dispensaries may become the bigger news story. Imagine, multi-million or multi-billion dollar market cap companies distributing an illegal drug for medicinal use.

Maybe it's the move that triggers a nation-wide pot revolution.

-- Written by Joe Deaux in New York.

>Contact by Email.

2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,891.88 +87.08 0.49%
S&P 500 2,070.43 -0.22 -0.01%
NASDAQ 4,767.6210 +2.2410 0.05%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs